Patients must have measurable or evaluable disease
74.0
Participants must have measurable or evaluable disease
130.0
Radiologically measurable or clinically evaluable disease
1120.0
Patients must have measurable or evaluable disease
68.0
Patients must have measurable or evaluable disease
330.0
Part A: Patients must have either measurable or evaluable disease
154.0
Parts A & C: patients must have either measurable or evaluable disease
484.0
Parts B, D & E: patients must have measurable disease for Parts B1-B6, D1-D5, E3 and E4; melanoma patients in Part B7 must have either measurable or evaluable disease; neuroblastoma patients in Parts B8 and D6 must be evaluable for MIBG response without evidence of RECIST measurable lesions
484.0
Disease status:* Part A: Patients must have either measurable or evaluable disease* Parts B and C: Patients must have measurable disease on imaging
81.0
CA-125 only disease without RECIST 1.1 measurable or otherwise evaluable disease
549.0
Patients must have measurable or evaluable disease
46.0
Patients must have either measurable or evaluable disease
67.0
Patients must have either measurable or evaluable disease
65.0
Patients must have either measurable or evaluable disease
36.0
Patients must have measurable or evaluable disease
38.0
Patients must have either measurable or evaluable disease
51.0
